Healthlead PCL (BKK:HL) Marketable Securities: ฿492 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:HL Healthlead PCL BKK:HL
72 GF Score
Price ฿5.10
GF Value ฿11.00
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL Marketable Securities?

Healthlead PCL BKK:HL -4.67% 72 Marketable Securities is ฿492 Mil as of Mar. 2026. GuruFocus rates BKK:HL with a GF Score™ of 72/100 and a GF Value™ of ฿11.00 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Healthlead PCL's Marketable Securities for the quarter that ended in Mar. 2026 was ฿492 Mil.

Healthlead PCL's annual Marketable Securities increased from Dec. 2023 (฿223 Mil) to Dec. 2024 (฿348 Mil) and increased from Dec. 2024 (฿348 Mil) to Dec. 2025 (฿512 Mil).

Healthlead PCL  (BKK:HL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Healthlead PCL Marketable Securities Related Terms

Healthlead PCL Marketable Securities Historical Data

* Premium members only.

The historical data trend for Healthlead PCL's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL Marketable Securities Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 506.97 223.06 347.95 511.90

Healthlead PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 391.17 464.40 451.03 511.90 491.62
BKK:HL
72GF Score
Healthlead PCL BKK:HL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthlead PCL Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ฿492 Mil mean?
Healthlead PCL (BKK:HL) has a Marketable Securities of ฿492 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Marketable Securities too high?
Healthlead PCL's current Marketable Securities is ฿492 Mil. Overall, Healthlead PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Marketable Securities compare to competitors?
Healthlead PCL's Marketable Securities of ฿492 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Marketable Securities is ฿492 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿11.00, compared to a current price of ฿5.10 — trading 53.6% below its estimated fair value. The current Marketable Securities is ฿492 Mil. Healthlead PCL's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Marketable Securities is ฿492 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿5.10 is trading 53.6% below its estimated GF Value™ of ฿11.00. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • Marketable Securities: ฿492 Mil
  • GF Value™: ฿11.00 vs. price of ฿5.10 (53.6% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
72GF Score

Get the complete analysis for BKK:HL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.10
Price
฿11.00
GF Value